Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosis

BackgroundStress of the endoplasmic reticulum (ER) leading to activation of the unfolded protein response (UPR) and alveolar epithelial cell (AEC) apoptosis may play a role in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Our objectives were to determine whether circulating caspase-cleaved cytokeratin-18 (cCK-18) is a marker of AEC apoptosis in IPF, define the relationship of cCK-18 with activation of the UPR, and assess its utility as a diagnostic biomarker.MethodsIPF and normal lung tissues were stained with the antibody (M30) that specifically binds cCK-18. The relationship between markers of the UPR and cCK-18 was determined in AECs exposed in vitro to thapsigargin to induce ER stress. cCK-18 was measured in serum from subjects with IPF, hypersensitivity pneumonitis (HP), nonspecific interstitial pneumonia (NSIP), and control subjects.ResultscCK-18 immunoreactivity was present in AECs of IPF lung, but not in control subjects. Markers of the UPR (phosphorylated IRE-1α and spliced XBP-1) were more highly expressed in IPF type II AECs than in normal type II AECs. Phosphorylated IRE-1α and cCK-18 increased following thapsigargin-induced ER stress. Serum cCK-18 level distinguished IPF from diseased and control subjects. Serum cCK-18 was not associated with disease severity or outcome.ConclusionscCK-18 may be a marker of AEC apoptosis and UPR activation in patients with IPF. Circulating levels of cCK-18 are increased in patients with IPF and cCK-18 may be a useful diagnostic biomarker.

• Publication year

  2012

• Venue

  Respiratory Research

• Publication date

  2012-11-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/1465-9921-13-105PMID 23167970PMCID 3547729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute Exacerbations of Idiopathic Pulmonary Fibrosis

  2013cited by this paper
• References Subscriptions Permissions Email Alerts TGF-β1 as an Enhancer of Fas-Mediated

  2013cited by this paper
• Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.

  2012cited by this paper
• American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management

  2011cited by this paper
• Cough predicts prognosis in idiopathic pulmonary fibrosis

  2011cited by this paper
• Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis.

  2011cited by this paper
• Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.

  2010cited by this paper
• Epithelial apoptosis as a clinical marker in idiopathic interstitial pneumonia.

  2010cited by this paper
• The UPR and cell fate at a glance

  2010cited by this paper
• Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis.

  2010cited by this paper
• Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.

  2009cited by this paper
• IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates.

  2009cited by this paper
• Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.

  2009cited by this paper
• Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis.

  2008influential reference
• MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis

  2008cited by this paper
• Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection.

  2008influential reference
• Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project.

  2008cited by this paper
• Acute exacerbations of idiopathic pulmonary fibrosis.

  2007cited by this paper
• CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.

  2007cited by this paper
• Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis.

  2007cited by this paper
• A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.

  2006cited by this paper
• Prognostic value of circulating KL‐6 in idiopathic pulmonary fibrosis

  2006cited by this paper
• Endoplasmic reticulum stress in health and disease.

  2006influential reference
• Detection of epithelial cell death in the body by cytokeratin 18 measurement.

  2005influential reference
• Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts.

  2003cited by this paper
• Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias

  2003cited by this paper
• American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors

  2002cited by this paper
• American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

  2002cited by this paper
• Serum surfactant proteins‐A and ‐D as biomarkers in idiopathic pulmonary fibrosis

  2002cited by this paper
• TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells.

  2002cited by this paper
• Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP)

  2001cited by this paper
• Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement

  2000cited by this paper
• American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

  2000cited by this paper
• international consensus statement

  2000cited by this paper
• Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent.

  2000cited by this paper
• Immunocytochemical detection and mapping of a cytokeratin 18 neo‐epitope exposed during early apoptosis

  1999influential reference
• Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung.

  1998cited by this paper
• Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis.

  1998cited by this paper
• Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.

  1998cited by this paper
• Clinical Investigations: BAC, UIP, SODSurvival in Patients With Cryptogenic Fibrosing Alveolitis: A Population-Based Cohort Study

  1998cited by this paper
• Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern.

  1998cited by this paper
• Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung.

  1998cited by this paper

• Diagnosis of early idiopathic pulmonary fibrosis: current status and future perspective

  2025cites this paper
• Biomarkers for Early Diagnosis of Idiopathic Pulmonary Fibrosis: A Systematic Review

  2024cites this paper
• The Dawn of Precision Medicine in Fibrotic Interstitial Lung Disease

  2024cites this paper
• Exploring the Role of Biomarkers Associated with Alveolar Damage and Dysfunction in Idiopathic Pulmonary Fibrosis—A Systematic Review

  2023influential citation
• Pharmacodynamics of Cyclin D1 Degradation in Ovarian Cancer Xenografts with Repeated Oral SHetA2 Dosing

  2023cites this paper
• Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis

  2023cites this paper
• Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?

  2023cites this paper
• Precision medicine advances in idiopathic pulmonary fibrosis

  2023cites this paper
• Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis

  2023cites this paper
• Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option

  2022cites this paper
• Pharmacological targeting of endoplasmic reticulum stress in disease

  2021cites this paper
• Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions

  2021cites this paper
• Pharmacological targeting of endoplasmic reticulum stress in disease

  2021cites this paper
• The ageing lung under stress

  2020cites this paper
• Role of unfolded proteins in lung disease

  2020cites this paper
• Cigarette Smoke Extract Promotes Human Lung Myofibroblast Differentiation by the Induction of Endoplasmic Reticulum Stress

  2019cites this paper
• Pulmonary endoplasmic reticulum stress—scars, smoke, and suffocation

  2019cites this paper
• Regulation and role of the ER stress transcription factor CHOP in alveolar epithelial type-II cells

  2019cites this paper
• Traffic‐related air pollution associations with cytokeratin‐18, a marker of hepatocellular apoptosis, in an overweight and obese paediatric population

  2018cites this paper
• Biomarkers in idiopathic pulmonary fibrosis.

  2018cites this paper
• Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement

  2018cites this paper
• Biomarkers in Idiopathic Pulmonary Fibrosis

  2018cites this paper
• Personalised medicine in interstitial lung diseases

  2018cites this paper
• Endoplasmic reticulum stress, a new wrestler, in the pathogenesis of idiopathic pulmonary fibrosis.

  2017cites this paper
• Serum Level of Cytokeratin-18/M30 Antigen is Increased in the Cases with Impaired Glucose Tolerance

  2017cites this paper
• The role of Endoplasmic Reticulum (ER) stress in pulmonary fibrosis

  2016influential citation
• miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis

  2016cites this paper
• Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

  2016cites this paper
• Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis

  2015cites this paper
• Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers

  2015cites this paper
• Personalized medicine in idiopathic pulmonary fibrosis: facts and promises

  2015cites this paper
• Pathogenesis of idiopathic pulmonary fibrosis.

  2014cites this paper
• CALL FOR PAPERS Biomarkers in Lung Diseases: from Pathogenesis to Prediction to New Therapies Molecular biomarkers in idiopathic pulmonary fibrosis

  2014cites this paper
• Idiopathic Pulmonary Fibrosis Clinical Trials: Evolving Concepts

  2014cites this paper
• Asbestos-induced alveolar epithelial cell apoptosis. The role of endoplasmic reticulum stress response.

  2013cites this paper